REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX) is a healthcare company (biotechnology) based in the United States. The share price is $7.24, down 1.09% on the day, which values the company at $478.73M. Price as of 18 Nov 2026, 11:08 UTC, from Yahoo Finance.

Key facts

Share price
$7.24−1.09% today
Market value
$478.73M
Funk Score
35/100
Against its own history
Well below its usual priceusual price $17.37
200-week average
$12.7743% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

REGENXBIO Inc. in more detail

RGNX trades at -2.2× next year's expected earnings, 3.1× sales. Measured against its own history, the price is 58% below what its usual multiples would imply ($17.37) — well below its usual price. It sits 43% below its 200-week average of $12.77.

Over the last five fiscal years REGENXBIO Inc. has compounded revenue 2.0% a year. Its Funk Score is 35 out of 100 (financial strength 3.9, profitability 0.5, growth 4.6, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

REGENXBIO Inc. (RGNX): questions and answers

What is REGENXBIO Inc.'s market cap?

REGENXBIO Inc. is valued at $478.73M at a share price of $7.24.

Is RGNX overvalued or undervalued?

Against its own history, RGNX is well below its usual price: the price is 58% below the $17.37 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is RGNX above its 200-week moving average?

No. RGNX is 43.3% below its 200-week average of $12.77. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is REGENXBIO Inc. growing?

Over the last five fiscal years REGENXBIO Inc.'s revenue grew 2.0% a year; over ten years revenue grew 36.5% a year.

Does RGNX pay a dividend?

REGENXBIO Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “REGENXBIO Inc. (RGNX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/RGNX

Underlying data: Yahoo Finance; company filings with the SEC.